Skip to main content
SpringerLink
Log in

Shared Genetic Risk Factors in Autoimmune Liver Disease

  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

To determine if shared genetic risk factors for autoimmune liver disease affect clinical manifestations, we evaluated 271 patients and 92 normal subjects by DNA-based techniques. Genetic risk factors were intermixed in all conditions, and frequency varied according to disease type. DR4 distinguished autoimmune hepatitis (P = 0.0002) and primary biliary cirrhosis (P = 0.004) from primary sclerosing cholangitis. DR52 distinguished primary sclerosing cholangitis from autoimmune hepatitis (P = 0.0007) and primary biliary cirrhosis (P = 0.00007) and DR3 distinguished autoimmune hepatitis (P = 0.002) and primary sclerosing cholangitis (P = 0.0005) from primary biliary cirrhosis. Only the occurrence of DR4 in primary sclerosing cholangitis was lower than in normal subjects (P = 0.02). Patients with mixed genetic risk factors did not have distinctive features or manifestations of hybrid conditions. We conclude that patients with shared genetic risk factors do not have characteristic features nor do they have overlap syndromes. DR4 may be protective against primary sclerosing cholangitis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. Donaldson PT, Doherty DG, Hayllar KM, McFarlane IG, Johnson PJ, Williams R: Susceptibility to autoimmune chronic active hepatitis: human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors. Hepatology 13:701–706, 1991

    Google Scholar 

  2. Strettell MDJ, Donaldson PT, Thomson LJ, Santrach PJ, Moore SB, Czaja AJ, Williams R: Allelic basis for HLAencoded susceptibility to type 1 autoimmune hepatitis. Gastroenterology 112:2028–2035, 1997

    Google Scholar 

  3. Sanchez-Urdazpal L, Czaja AJ, van Hoek B, Krom RAF, Wiesner RH: Prognostic features and role of liver transplantation in severe corticosteroid-treated autoimmune chronic active hepatitis. Hepatology 15:215–221, 1992

    Google Scholar 

  4. Czaja AJ, Strettell MDJ, Thomson LJ, Santrach PJ, Moore SB, Donaldson PT, Williams R: Associations between alleles of the major histocompatibility complex and type 1 autoimmune hepatitis. Hepatology 25:317–323, 1997

    Google Scholar 

  5. Czaja AJ, Carpenter HA, Santrach PJ, Moore SB: Significance of HLA DR4 in type 1 autoimmune hepatitis. Gastroenterology 105:1502–1507, 1993

    Google Scholar 

  6. Czaja AJ, Donaldson PT: Genetic susceptibilities for immune expression and liver cell injury in autoimmune hepatitis. Immunol Rev 174:250–259, 2000

    Google Scholar 

  7. Gores GJ, Moore SB, Fisher LD, Powell FC, Dickson ER: Primary biliary cirrhosis: associations with class II major histocompability complex antigens. Hepatology 7:889–892, 1987

    Google Scholar 

  8. Manns MP, Bremm A, Schneider PM, Notghi A, Gerken G, Prager-Eberle M, Stradmann-Bellinghausen B, Meyer zum Buschenfelde K-H, Rittner C: HLA DRw8 and complement C4 deficiency as risk factors in primary biliary cirrhosis. Gastroenterology 101:1367–1373, 1991

    Google Scholar 

  9. Mehal WZ, Gregory WL, Lo Y-MD, Cross SJ, Fleming KA, Bassendine MF, James OFW, Campbell RD, Chapman RW, Rosenberg WMC: Defining the immunogenetic susceptibility to primary biliary cirrhosis. Hepatology 20:1213–1219, 1994

    Google Scholar 

  10. Onishi S, Sakamaki T, Maeda T, Iwamura S, Tomita A, Saibara T, Yamamoto Y: DNA typing of HLA class II genes: DRB1*0803 increases the susceptibility of Japanese to primary biliary cirrhosis. J Hepatol 21:1053–1060, 1994

    Google Scholar 

  11. Prochazka EJ, Terasaki PI, Park MS, Golstein LI, Busuttil RW: Association of primary sclerosing cholangitis with HLADRw52a. N Engl J Med 322:1842–1844, 1990

    Google Scholar 

  12. Farrant JM, Doherty DG, Donaldson PT, Vaughan RW, Hayllar KM, Welsh KI, Eddleston ALWF, Williams R: Amino acid substitutions at position 38 of the DRb polypeptide confer susceptibility to and protection from primary sclerosing cholangitis. Hepatology 16:390–395, 1992

    Google Scholar 

  13. Czaja AJ: Chronic active hepatitis: The challenge for a new nomenclature. Ann Intern Med 119:510–517, 1993

    Google Scholar 

  14. Czaja AJ: The variant forms of autoimmune hepatitis. Ann Intern Med 125:588–598, 1996

    Google Scholar 

  15. Czaja AJ: Frequency and nature of the variant syndromes of autoimmune liver disease. Hepatology 28:360–365, 1998

    Google Scholar 

  16. Czaja AJ, Carpenter HA, Santrach PJ, Moore SB: Autoimmune cholangitis within the spectrum of autoimmune liver disease. Hepatology 31:1231–1238, 2000

    Google Scholar 

  17. Chazouilleres O, Wendum D, Serfaty L, Montebault S, Rosmorduc O, Poupon R: Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: Clinical features and response to therapy. Hepatology 28:296–301, 1998

    Google Scholar 

  18. McNair AN, Moloney M, Portmann BC, Williams R, McFarlane IG: Autoimmune hepatitis overlapping with primary sclerosing cholangitis in 5 cases. Am J Gastroenterol 93:777–784, 1998

    Google Scholar 

  19. Johnson PJ, McFarlane IG, Alvarez F, Bianchi FB, Bianchi L, Burroughs A, Chapman RW, Czaja AJ, Desmet V, Edleston ALWF, Gerber MA, Hoofnagle JH, Kakumu S, MacSween RNM, Maddrey WC, Manns MP, Meyer zum Buschenfelde K-H, Mieli-Vergani G, Portmann BC, Reed WD, Schalm SW, Scheuer PJ, Toda G, Tsuji T, Tygstrup N, Vergani D, Zeniya M: Meeting report. International Autoimmune Hepatitis Group. Hepatology 18:998–1005, 1993

    Google Scholar 

  20. Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL, Chapman RW, Cooksley WGE, Czaja AJ, Desmet VJ, Donaldson PT, Eddleston ALWF, Fainboim L, Heathcote J, Homberg J-C, Hoofnagle JH, Kakumu S, Krawitt EL, Mackay IR, MacSween RNM, Maddrey WC, Manns MP, Mc-Farlane IG, Meyer zum Buschenfelde K-H, Mieli-Vergani G, Nakanuma Y, Nishioka M, Penner E, Porta G, Portmann BC, Reed WD, Rodes J, Schalm SW, Scheuer PJ, Schrumpf E, Seki T, Toda G, Tsuji T, Tygstrup N, Vergani D, Zeniya M. International Autoimmune Hepatitis Group report: Review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 31: 929–938, 1999

    Google Scholar 

  21. Czaja AJ, Manns MP: The validity and importance of subtypes of autoimmune hepatitis: A point of view. Am J Gastroenterol 90:1206–1211, 1995

    Google Scholar 

  22. Wiesner RH, LaRusso NF, Ludwig J, Dickson ER: Comparison of the clinicopathologic features of primary sclerosing cholangitis and primary biliary cirrhosis. Gastroenterology 88:108–114, 1985

    Google Scholar 

  23. Wiesner RH, LaRusso NF: Clinicopathologic features of the syndrome of primary sclerosing cholangitis. Gastroenterology 79:200–206, 1980

    Google Scholar 

  24. Czaja AJ, Cassani F, Cataleta M, Valentini P, Bianchi FB: Frequency and significance of antibodies to actin in type 1 autoimmune hepatitis. Hepatology 24:1068–1073, 1996

    Google Scholar 

  25. Czaja AJ, Cassani F, Cataleta M, Valentini P, Bianchi FB: Antinuclear antibodies and patterns of nuclear immunofluorescence in type 1 autoimmune hepatitis. Dig Dis Sci 42:1688–1696, 1997

    Google Scholar 

  26. Czaja AJ, Carpenter HA, Manns MP: Antibodies to soluble liver antigen, P450IID6, and mitochondrial complexes in chronic hepatitis. Gastroenterology 105:1522–1528, 1993

    Google Scholar 

  27. Czaja AJ, Manns MP, Homburger HA: Frequency and significance of antibodies to liver/kidney microsome type 1 in adults with chronic active hepatitis. Gastroenterology 103:1290–1295, 1992

    Google Scholar 

  28. Czaja AJ, Carpenter HA, Santrach PJ, Moore SB: Genetic predispositions for the immunological features of chronic active hepatitis. Hepatology 18:816–822, 1993

    Google Scholar 

  29. Czaja AJ, Dos Santos RM, Porto A, Santrach PJ, Moore SB: Immune phenotype of chronic liver disease. Dig Dis Sci 43:2149–2155, 1998

    Google Scholar 

  30. Czaja AJ, Manns MP, McFarlane IG, Hoofnagle JH: Autoimmune hepatitis: The investigational and clinical challenges. Hepatology 31:1194–1200, 2000

    Google Scholar 

  31. Mieli-Vergani G, Lobo-Yeo A, McFarlane BM, McFarlane IG, Mowat AP, Vergani D: Different immune mechanisms leading to autoimmunity in primary sclerosing cholangitis and autoimmune chronic active hepatitis of childhood. Hepatology 9:198–203, 1989

    Google Scholar 

  32. Cookson S, Constantini PK, Clare M, Underhill JA, Bernal W, Czaja AJ, Donaldson PT: Frequency and nature of cytokine gene polymorphisms in type 1 autoimmune hepatitis. Hepatology 30:851–856, 1999

    Google Scholar 

  33. Czaja AJ, Cookson S, Constantini PK, Clare M, Underhill JA, Donaldson PT: Cytokine polymorphisms associated with clinical features and treatment outcome in type 1 autoimmune hepatitis. Gastroenterology 117:645–652, 1999

    Google Scholar 

  34. Agarwal K, Czaja AJ, Jones DEJ, Donaldson PT: CTLA-4 gene polymorphism and susceptibility to type 1 autoimmune hepatitis. Hepatology 31:49–53, 2000.

    Google Scholar 

  35. Czaja AJ, Sievers C, Zein NN: Nature and behavior of serum cytokines in type 1 autoimmune hepatitis. Dig Dis Sci 45: 1028–1035, 2000

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Gastroenterology and Hepatology and the Department of Laboratory Medicine and Pathology, Mayo Clinic and Mayo Foundation, Rochester, Minnesota

    Albert J. Czaja, Paula J. Santrach & S. Breanndan Moore

Authors
  1. Albert J. Czaja
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Paula J. Santrach
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. Breanndan Moore
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Czaja, A.J., Santrach, P.J. & Moore, S.B. Shared Genetic Risk Factors in Autoimmune Liver Disease. Dig Dis Sci 46, 140–147 (2001). https://doi.org/10.1023/A:1005670111068

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1005670111068

Search

Navigation